CD38 and plasma cell neoplasm: In the case of plasma cell neoplasms (example shown in Figure 11), another plasma cell marker is needed to identify the plasma cells (CD138, BCMA, etc.)or a CD38 antibody that is not blocked by Daratumab (for example, clone JK36).